KATIE GRYB: Open Payments
NPI 1023573037 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$135 in 8 payments from 8 companies in 2025. Trend: 2023 $96 · 2024 $193 · 2025 $135
Food & beverage: $135
| Company | Payments | Amount |
|---|---|---|
| SANOFI PASTEUR INC. | 1 | $24 |
| Novo Nordisk Inc | 1 | $22 |
| TOLMAR, INC. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, JATENZO, XIFAXAN, JARDIANCE, AIRSUPRA, TRELEGY ELLIPTA, VOQUEZNA.
Industry payments across NC — which companies pay providers there.
